| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 661011 | 02218020 | AXURA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | AXURA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02218020/02218020_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02218020/02218020_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1839 | MERZ THERAPEUTICS IBERIA S.L.U. | 2008-06-13 | 1 | 1 | 1 | 2008-06-13 | 2008-06-13 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661315 | 69976 | VENLAFAXINA RETARD KRKA 37.5 mg CAPSULAS DURAS DE LIBERACION PROLONGADA | VENLAFAXINA RETARD KRKA 37.5 mg CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 37,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69976/69976_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69976/69976_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2008-07-18 | 1 | 1 | 1 | 2008-07-18 | 2008-07-18 | 1 | 2011-06-02 | View Edit Delete | ||||||||||||
| 661317 | 69977 | VENLAFAXINA RETARD KRKA 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD KRKA 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 75 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69977/69977_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69977/69977_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2008-07-18 | 1 | 1 | 1 | 2008-07-18 | 2008-07-18 | 1 | 2012-12-11 | View Edit Delete | ||||||||||||
| 661319 | 69978 | VENLAFAXINA RETARD KRKA 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD KRKA 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 150 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69978/69978_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69978/69978_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2008-07-18 | 1 | 1 | 1 | 2008-07-18 | 2008-07-18 | 1 | 2012-12-11 | View Edit Delete | ||||||||||||
| 661250 | 61109 | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA | CRISTALMINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEA, 1 frasco de 25 ml | 10 mg/ml | 6 | 25 | 26 | 1 frasco de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61109/61109_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61109/61109_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1996-04-01 | 1 | 1 | 1 | 1996-04-01 | 2008-07-09 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 660559 | 67635 | GLUCOSA B.BRAUN 70% SOLUCIÓN PARA PERFUSIÓN | GLUCOSA B.BRAUN 70% SOLUCIÓN PARA PERFUSIÓN , 10 frascos 500 ml | 70% | 6 | 10 | 48 | 10 frascos 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67635/67635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67635/67635_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2006-03-21 | 1 | 1 | 1 | 2006-03-21 | 2008-02-18 | 0 | 2011-06-20 | View Edit Delete | ||||||||||||
| 660631 | 69659 | ACOMICIL 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACOMICIL 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 25 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69659/69659_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69659/69659_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2008-04-17 | 1 | 1 | 1 | 2008-04-17 | 2008-04-17 | 1 | 2011-03-04 | View Edit Delete | ||||||||||||
| 660632 | 69660 | ACOMICIL 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACOMICIL 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 50 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69660/69660_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69660/69660_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2008-04-17 | 1 | 1 | 1 | 2008-04-17 | 2008-04-17 | 1 | 2011-03-04 | View Edit Delete | ||||||||||||
| 660633 | 69661 | ACOMICIL 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACOMICIL 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 100 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69661/69661_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69661/69661_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2008-04-17 | 1 | 1 | 1 | 2008-04-17 | 2008-04-17 | 1 | 2011-03-04 | View Edit Delete | ||||||||||||
| 660634 | 69662 | ACOMICIL 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ACOMICIL 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 200 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69662/69662_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69662/69662_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2008-04-17 | 1 | 1 | 1 | 2008-04-17 | 2008-04-17 | 1 | 2011-03-04 | View Edit Delete | ||||||||||||
| 661658 | 70147 | IBUSTICK 50 mg/g GEL | IBUSTICK 50 mg/g GEL, 1 tubo de 60 g | 50 mg/g | 6 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70147/70147_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70147/70147_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5478 | FARMASIERRA LABORATORIOS S.L. | 2008-10-16 | 1 | 1 | 1 | 2008-10-16 | 2008-10-16 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661466 | 52373 | AMOXICILINA ARDINE 125 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 125 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml | 125 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52373/52373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52373/52373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1974-05-01 | 1 | 1 | 1 | 1974-05-01 | 2008-09-26 | 1 | 2011-02-08 | 711028 | View Edit Delete | |||||||||||
| 661467 | 53626 | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG , 1 frasco de 120 ml | 250 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53626/53626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53626/53626_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1976-02-01 | 1 | 1 | 1 | 1976-02-01 | 2008-09-26 | 1 | 2011-02-08 | 939314 | View Edit Delete | |||||||||||
| 661265 | 69955 | APIREDOL 100 mg/ml SOLUCION ORAL | APIREDOL 100 mg/ml SOLUCION ORAL, 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69955/69955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69955/69955_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7335 | IONFARMA S.L. | 2008-07-11 | 1 | 1 | 1 | 2008-07-11 | 2008-07-11 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661266 | 69955 | APIREDOL 100 mg/ml SOLUCION ORAL | APIREDOL 100 mg/ml SOLUCION ORAL, 1 frasco de 60 ml | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69955/69955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69955/69955_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7335 | IONFARMA S.L. | 2008-07-11 | 1 | 1 | 1 | 2008-07-11 | 2008-07-11 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660936 | 62044 | AGUA PARA PREPARACIONES INYECTABLES BEXEN DISOLVENTE PARA USO PARENTERAL | AGUA PARA PREPARACIONES INYECTABLES BEXEN DISOLVENTE PARA USO PARENTERAL , 1 ampolla de 5 ml | N/A (agua estéril) | 6 | 1 | 1 | 1 ampolla de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62044/62044_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62044/62044_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3978 | OIARSO SOCIEDAD COOPERATIVA | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660782 | 69726 | DALSY 40 mg/ml SUSPENSION ORAL | DALSY 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69726/69726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69726/69726_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2008-04-07 | 1 | 1 | 1 | 2008-04-07 | 2008-04-07 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661397 | 62015 | TIONER 100 MG/ML SOLUCION ORAL | TIONER 100 MG/ML SOLUCION ORAL , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62015/62015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62015/62015_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 660432 | 69553 | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69553/69553_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69553/69553_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2008-01-28 | 1 | 1 | 1 | 2008-01-28 | 2008-01-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 661454 | 97039003 | CYSTAGON 150 mg CAPSULAS DURAS | CYSTAGON 150 mg CAPSULAS DURAS, 100 cápsulas | 150 mg | 6 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97039003/97039003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97039003/97039003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2000-05-30 | 1 | 1 | 1 | 2000-05-30 | 2000-05-30 | 1 | 2011-05-10 | View Edit Delete |
Page 170 of 1035, showing 20 records out of 20684 total, starting on record 3381, ending on 3400